Week in Review: Facebook and Other Venture-Backed IPOs Grab Headlines
Posted by | May 18, 2012
The big news today is the Facebook IPO. The company that famously started in a Harvard dorm room set three records at IPO, including the largest valuation for a venture-backed IPO, the most capital raised, and the most active acquirer pre-IPO. All this attention has also brought Facebook a number of detractors, some of whom warn of potential advertising concerns after GM stopped advertising on the site, issues for which the company will now have to answer to the public. Regardless of the hype, Facebook’s stock price finished the day relatively flat, closing merely pennies above its opening price at $38.18.
In fact, 2012 saw the most first quarter venture-backed IPOs since 2007. But Sarah Johnson from CFO magazine notes that the first quarter of 2011 also saw a high number of venture-backed IPOs. But then those numbers fell off in the second half of the year. The only question now is whether history will repeat itself or if 2012’s numbers represent a true upward trend. Time will only tell.
Here’s the latest Safeguard Scientifics partner company news:
- AdvantEdge Healthcare Solutions completed a SOC 1 examination for the first of its operations centers. The completion of this examination demonstrates that AHS is able to offer its customers a substantially higher level of assurance and operational visibility than organizations that do not complete the SOC 1. AHS has started the certification process for its other centers.
- Medivo was featured in iMedical Apps, an online medical publication that provides commentary and reviews on mobile medical technology and applications.
The feedback? Medivo’s interface beats most if not all other population management systems; Patient engagement piece is unique and robust; Potential to address patient symptom tracking workflow integration challenge for providers; and it’s free!
- NovaSom was featured in Medical Device Daily, and highlights that the company’s home sleep test for obstructive sleep apean (OSA) is starting to take off with payer backing. “More than 18 million people in the U.S. suffer from Obstructive Sleep Apnea (OSA). About 85% of sufferers are undiagnosed and therefore untreated generating significant medical expense for patients and the healthcare system.
- NuPathe announced its first quarter 2012 financial results and highlights, which included two allowances for U.S. patents.
- Putney welcomed Chris Lewis as its new vice president of finance. His previous experience in the animal health industry includes 12 years at IDEXX Laboratories, where he served as senior finance manager for the Production Animal Division.
- The Martin Group, a strategic branding and creative marketing firm, headquartered in Buffalo, New York, featured Spongecell in a blog post, describing Spongecell ads as “eye-catching, engaging and effective”.
- ThingWorx released version 3.0, which adds SQUEAL, a search-based intelligence and analytics tool, and AlwaysOn, a patented communication infrastructure for the connected world, to the ThingWorx platform.
To read more of our Week in Review series, please use the following feed: safeguardscientifics.com/WeekInReview. Have a great weekend!
